Indigo Paints ends FY26 with steady growth, strong margins, and a sharper push for market share
Ask Iris
Indigo Paints closed FY26 with modest revenue growth but continued to stand out on profitability, even in a quarter marked by supply disruptions and raw material volatility. On a consolidated basis, revenue for FY26 came in at INR 1,405.0 crore, up 4.8% year on year. EBITDA rose to INR 254.8 crore and PAT (excluding an exceptional gratuity-related item) increased to INR 152.2 crore.
The fourth quarter carried the most narrative weight. Management described a demand recovery that began around November 2025, but noted that the Middle East conflict in March 2026 led to an abrupt supply chain breakdown and sharp inflation in key raw materials. Despite that, Indigo’s standalone Q4 revenue from operations grew 8.4% YoY to INR 397.9 crore, while the company retained a high gross margin profile.
Q4 FY26: resilience through mix, but PAT hit by treasury MTM
The most visible operational highlight in Q4 FY26 was margin resilience. Standalone gross margin was reported at 48.6% versus 47.4% in Q4 FY25, even as management cited raw material price jumps of 50% to 100% during March. The company attributed this to the growing share of differentiated products, reinforcing its longer-term positioning around premiumization and niche offerings.
At the operating profit line, Q4 standalone EBITDA grew 6.8% YoY to INR 91.7 crore with a margin of 23.0%. Management also highlighted that Indigo’s EBITDA margin tends to peak in Q4 due to seasonal product mix.
Net profit growth was more muted. Standalone Q4 PAT rose marginally to INR 57.3 crore, with PAT margin declining to 14.4% from 15.3% in the year-ago quarter. The key driver was a steep drop in other income, which fell from INR 5.6 crore in Q4 FY25 to INR 0.19 crore in Q4 FY26, due to mark-to-market losses in treasury income amid adverse bond yield movements.
FY26 performance: two halves and continued profitability leadership
Management characterized FY26 as a year with two distinct halves: a subdued H1 and stronger H2 as demand improved and internal growth initiatives gained traction. On a standalone basis, revenue from operations grew 4.1% to INR 1,330.1 crore. EBITDA improved to INR 246.7 crore, with margin expanding to 18.5% from 18.1% in FY25. PAT (excluding an exceptional gratuity provision of INR 5.85 crore) rose 4.0% to INR 149.8 crore.
The consolidated picture tracked a similar pattern, with revenue of INR 1,405.0 crore, EBITDA of INR 254.8 crore, and PAT of INR 152.2 crore (excluding the exceptional item). Over the last five years on a consolidated basis (FY22 to FY26), the company disclosed revenue CAGR of 11.6%, EBITDA CAGR of 17.0%, and PAT CAGR of 16.0%.
Notes: PAT is referenced excluding exceptional gratuity-related items as disclosed by the company. Consolidated gross margin was presented as a quarterly comparison chart rather than full-year consolidated gross margin.
Growth drivers: network expansion, capacity ramp-up, and adjacencies
Indigo continued to expand its distribution footprint. As of Q4 FY26, it reported 55 depots, 19,352 active dealers, and 12,217 tinting machines across 28 states. Management indicated that the company is deepening presence in Tier 3 and Tier 4 markets while accelerating growth in Tier 1 and Tier 2 cities.
Product-wise, the company disclosed value and volume growth by category but did not disclose category-level revenue shares. In Q4 FY26, all categories posted positive growth, with Primers + Distempers + Others showing value growth of 14.9% and volume growth of 9.6%. For FY26, the fastest value growth was again in Primers + Distempers + Others at 11.1%.
A key operational milestone is capacity augmentation at Jodhpur. The upcoming water-based plant (90,000 KLPA) is in final commissioning, with trial production expected in June 2026. Management also stated that production has commenced in the solvent-based plant and putty plant in FY26. Importantly, it signaled that no major capex is envisaged till FY29, suggesting a shift toward higher free cash flow generation from FY27 onward.
Apple Chemie: scaling the waterproofing and construction chemicals adjacency
Indigo’s subsidiary, Apple Chemie India Ltd, remained a strong growth contributor. In Q4 FY26, Apple Chemie revenue grew 34.7% YoY to INR 27.5 crore, while FY26 revenue grew 17.8% to INR 75.1 crore. Management attributed earlier softness in FY26 to delayed payments in infrastructure projects, particularly in Maharashtra, which eased later in the year.
Apple Chemie commissioned and operationalized a new sealant plant at the Nagpur facility. Management cited strong order visibility and guided for 30% plus growth in FY27. It also shared that Apple Chemie’s gross margins hover around 40% (plus or minus 1%), depending on product mix.
Outlook: a more aggressive stance on market share, with margin trade-offs
The most important forward-looking message from management was a clear tilt toward faster growth and market share gains. It stated that it has been achieving double-digit gross revenue growth for the past five months and expects the trend to continue. It also noted that the industry implemented multiple price hikes of about 12% following raw material inflation in March 2026.
More notably, management indicated it is willing to accept moderate gross margin compression in pursuit of higher growth, while aiming to keep EBITDA margins broadly intact. In the earnings call, management explained that this would likely come through higher spends on trade schemes and influencer (painter and contractor) programs, which are netted off from revenue under Ind AS accounting.
Capital allocation also featured prominently. With the Jodhpur water-based plant nearing commissioning and no major capex planned till FY29, the company positioned itself for stronger cash generation. Reflecting this confidence, the Board proposed a dividend of INR 5.0 per share for FY26, compared to INR 3.5 per share in earlier years.
Closing takeaways
FY26 was not a high-growth year on the top line, but Indigo Paints maintained industry-leading margin characteristics and improved EBITDA margin on a full-year basis. The operational narrative now shifts to capacity readiness and a deliberate pivot toward faster market share gains, even at the cost of some gross margin moderation.
If the demand recovery holds and raw material volatility stabilizes, FY27 could be less about building capacity and more about converting the company’s network and brand investments into stronger growth and cash generation. Apple Chemie, with its improved order visibility and a 30% plus growth target, adds another lever to that story.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
